CEP83-DT

Across TCGA pan-cancer cohorts, CEP83-DT RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CEP83-DT data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher CEP83-DT RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CEP83-DT expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

UCS, MESO, and ACC are the cancer types where CEP83-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	II,III,IV	0.624	0.109	<.001	114	view →
MESO	OS	Median	All	0.272	0.496	<.001	112	view →
ACC	DFS	Tertile	All	0.449	0.883	<.001	71	view →
PAAD	DFS	Tertile	All	0.521	0.215	<.001	54	view →
KICH	DFS	Quartile	II,III,IV	0.375	1.000	.010	33	view →
LIHC	DFS	Quartile	All	0.422	0.600	.002	33	view →
READ	DFS	Tertile	All	0.888	0.276	.001	28	view →
KIRC	DFS	Quartile	IV	0.373	0.811	.007	26	view →
STAD	OS	Median	II,III,IV	0.500	0.633	.007	22	view →
OV	DFS	Quartile	IV	0.534	0.213	.003	18	view →
LUAD	OS	Median	II,III,IV	0.767	0.649	.004	13	view →
CHOL	DFS	Median	II,III,IV	0.627	0.123	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CEP83-DT–UCS (DFS)

Open the UCS breakdown →